Advancing Trials for HER2+ Breast Cancer With Leptomeningeal Metastasis
Barbara O’Brien, MD, discusses the next steps of the phase 2 TBCRC049 study for the treatment of patients with HER2-positive breast cancer and leptomeningeal metastasis.
Related Articles
JAB-8263 Monotherapy Demonstrates Early Promise in Myelofibrosis
JAB-8263 given at once-daily doses ranging from 0.125 mg to 0.3 mg proved to be well tolerated in patients with myelofibrosis.
Plasma cell and cancer stem cell crosstalk in glioblastoma
Plasma cells (PCs) are the main producers of antibodies and have context-dependent roles in tumor immunity. In this issue of Cancer Cell, Gao et al. report…
Blocking a cancer escape hatch
Fred Hutch graduate student Adam Nguyen has won a F31 training award from the NIH to study a complex molecule called Tie2 that aids and…
Infiltrating plasma cells maintain glioblastoma stem cells through IgG-Tumor binding
Gao et al. show that the plasma cells (PCs) can be recruited to glioblastoma stem cell (GSC) niches via the CCL2-CCR2 chemokine program and promote glioblastoma…
Recurrence-Free Interval Is Longer With Low ctDNA Levels at Baseline in TNBC
ctDNA was most frequently detected within 6 months post-treatment in patients with TNBC, aligning with the early recurrence pattern characteristic of the disease.
Personalizing Patient Communication in Oncology — Total Health
Presenters: Daniella Landau, CEO, MyCareCompass Health, Linda Fleisher, PhD, MPH, Fox Chase Cancer Center/Temple Health Conference: ASCO Direct™ Washington DC 2024
FDA Signals Potential for Standard Approval of Paxalisib in Glioblastoma
The FDA indicated paxalisib’s overall survival data could support standard approval in glioblastoma, as supported by GBM-AGILE study findings.
Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry study
This study analyzes the characteristics and outcomes of adults with secondary acute myeloid leukemia who previously received hypomethylating agents for prior myeloid neoplasms (HMA-sAML). This…
Alcohol, cannabis use after cancer: ‘eye-opening’ prevalence
A pair of studies by a team of Fred Hutch public health researchers found that a surprising number of people use alcohol and/or cannabis after…
Understanding the experience of Latinas in medical education: A qualitative study
Despite improvements in recruitment of Latina medical students, the percentage of Latina physicians has remained stagnant, suggesting unique barriers to retention and career advancement. This…